Our data suggest that antigen-presenting molecules of HLA-ABC on M-IFN-Dex exist; thus, it is expected that M-IFN-Dex could function as a cancer vaccine, effectively carrying tumor antigen peptides. The gene discussed is IFNA1; the disease is neoplasm.